Soleno Therapeutics (SLNO) Current Assets (2016 - 2019)
Historic Current Assets for Soleno Therapeutics (SLNO) over the last 7 years, with Q3 2019 value amounting to $11.6 million.
- Soleno Therapeutics' Current Assets rose 171.73% to $11.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $11.6 million, marking a year-over-year increase of 171.73%. This contributed to the annual value of $24.7 million for FY2018, which is 3710.13% up from last year.
- Per Soleno Therapeutics' latest filing, its Current Assets stood at $11.6 million for Q3 2019, which was up 171.73% from $16.6 million recorded in Q2 2019.
- In the past 5 years, Soleno Therapeutics' Current Assets registered a high of $24.7 million during Q4 2018, and its lowest value of $3.8 million during Q2 2016.
- In the last 5 years, Soleno Therapeutics' Current Assets had a median value of $10.3 million in 2017 and averaged $11.2 million.
- Per our database at Business Quant, Soleno Therapeutics' Current Assets surged by 170000.0% in 2015 and then plummeted by 5399.88% in 2016.
- Over the past 5 years, Soleno Therapeutics' Current Assets (Quarter) stood at $6.4 million in 2015, then crashed by 40.64% to $3.8 million in 2016, then skyrocketed by 373.37% to $18.0 million in 2017, then skyrocketed by 37.1% to $24.7 million in 2018, then plummeted by 52.94% to $11.6 million in 2019.
- Its Current Assets stands at $11.6 million for Q3 2019, versus $16.6 million for Q2 2019 and $20.9 million for Q1 2019.